|
Nr. |
Eintrag |
|
1 |
Boyd, P.A. et al.:
Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome.
In: BJOG: An International Journal of Obstetrics and Gynaecology, 2008, Vol. 115 (6), 689-696 |
|
2 |
Etchegary, Holly et al.:
The influence of experiential knowledge on prenatal screening and testing decisions
In: Genetic Testing, 2008, Vol. 12 (1), 115-124 |
|
3 |
Klemm, M. et al.:
Stammzellbasierte In-vitro-Modelle als Ersatz fuer Tiermodelle bei Toxizitaets- und Wirksamkeitspruefungen.
In: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2008, Vol. 51 (9), 1033 1038 |
|
4 |
Gagen, Wendy Jane; Bishop, Jeffrey P.:
Ethics, justification and the prevention of spina bifida
In: Journal of Medical Ethics, 2007, Vol. 33 (9), 501-507 |
|
5 |
Sharpe, Neil F.; Carter, Ronald F.:
Prenatal screening and diagnosis
In: Genetic Testing: Care, Consent, and Liability. Hoboken, NJ: Wiley-Liss; 2006: 163-218. |
|
6 |
Rautenstrauch, Julia:
Stammzellforscher in Aufbruchstimmung.
In: Deutsche Medizinische Wochenschrift, 2001, Vol. 126 (7), A 132-133 |
|
7 |
Forrester, Mathias B.; Merz, Ruth D.:
Prenatal Diagnosis and Elective Termination of Neural Tube Defects in Hawaii, 1986-1997
In: Fetal Diagnosis and Therapy, 2000, Vol. 15 (3), 146-151 |
|
8 |
Sancken, Ulrich:
Der sogenannte Triple-Test.
In: Deutsches Aerzteblatt, 2000, Vol. 97 (9), A-532-537 |
|
9 |
Mori, Koreaki; Basauri, Luciano:
Ethical issues in managed and rationed care for children with severe neurological disabilities: a questionnaire survey.
In: Child's Nervous System. , 1999, Vol. 15 (6-7), 342-346. |
|
10 |
Holtzman, Neil A.; Watson, Michael S.:
Promoting Safe and Effective Genetic Testing in the United States: Final Report of the Task Force on Genetic Testing.
In: In: Issued by the Task Force; 1997 Sep. 180 p.
1997 |
|
11 |
Mennuti, Michael:
A 35-year old pregnant woman considering maternal serum screening and amniocentesis.
In: JAMA. , 1996, Vol. 275 (18), 1440-1446. |
|
12 |
Petrinovich, Lewis:
Euthanasia: moral and medical issues.
In: > <his> Living and Dying Well. New York, NY: Plenum Press; 1996: 123-142. |
|
13 |
Sapin, Emmanuel:
The horizons of fetal medicine and its ethical consequences.
In: Dolentium Hominum: Church and Health in the World. , 1996, Vol. 31 (11th Yr., No. 1), 155-158. |
|
14 |
Browner, Carole H.; Press, Nancy Ann:
The normalization of prenatal diagnostic screening.
In: > Ginsburg, Faye D.; Rapp, Rayna, eds. Conceiving the New World Order: The Global Politics of Reproduction. Berkeley, CA: University of California Press; 1995: 307-322. |
|
15 |
Hook, Ernest B.; Waller, D. Kim:
Prenatal Screening for Neural Tube Defects and Chromosome Abnormalities: The Complexities of Program Evaluation [editorial]
In: Epidemiology, 1995, Vol. 6 (1), 1-4 |
|
16 |
Press, Nancy; Browner, C.H.:
Risk, autonomy, and responsibility: informed consent for prenatal testing.
In: Hastings Center Report. , 1995, Vol. 25 (3, Suppl.), S9-S12. |
|
17 |
Begleiter, Michael L.; Rogers, Jill Cellars:
Genetic counseling for a family with two distinct anomalies: a case report of a neural tube defect and 5p- syndrome in a fetus.
In: Journal of Genetic Counseling. , 1994, Vol. 3 (2), 87-93. |
|
18 |
Boss, Judith A.:
First trimester prenatal diagnosis: earlier is not necessarily better.
In: Journal of Medical Ethics. , 1994, Vol. 20 (3), 146-151. |
|
19 |
Grevengood, Chris et al.:
Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects.
In: Fetal Diagnosis and Therapy. , 1994, Vol. 9 (4), 273-277. |
|
20 |
Lockwood, Michael:
Sins of omission? The non-treatment of controls in clinical trials -- I.
In: > Erwin, Edward; Gendin, Sidney; Kleiman, Lowell, eds. Ethical Issues in Scientific Research: An Anthology. New York, NY: Garland; 1994: 201-217. |
